Literature DB >> 15005345

Spontaneous remission of Epstein-Barr virus-negative non-Hodgkin's lymphoma after withdrawal of cyclosporine in a patient with refractory anemia.

Masao Ogata1, Hiroshi Kikuchi, Keiji Ono, Eiichi Ohtsuka, Ayako Gamachi, Kenji Kashima, Masaru Nasu.   

Abstract

A 70-year-old man presented with pancytopenia in August 2000, and the results of a bone marrow examination performed in January 2001 confirmed the diagnosis of refractory anemia. He was treated with cyclosporine (CsA) at 3.3 mg/kg per day, and the pancytopenia improved. The patient complained of epigastralgia 21 months later, and a gastric endoscopic examination showed an ulcer with a cleaved bank. A biopsy revealed diffuse large B-cell lymphoma. In situ hybridization analysis detected no Epstein-Barr virus (EBV) in the lymphoma. CsA treatment was discontinued, and a gastrectomy was performed 31 days later. A detailed histologic examination revealed no infiltration of abnormal B-cells in the resected stomach. Although EBV-positive lymphoma is a known complication of immunosuppressive therapy, no causal association between immunosuppressants and EBV-negative lymphoma has been established. The spontaneous remission observed after the withdrawal of CsA treatment suggests that immunosuppressive therapy can be a pathogenic factor in a subset of EBV-negative lymphomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15005345     DOI: 10.1532/ijh97.03095

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  16 in total

1.  Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow.

Authors:  A Jonásova; R Neuwirtová; J Cermák; V Vozobulová; K Mociková; M Sisková; I Hochová
Journal:  Br J Haematol       Date:  1998-02       Impact factor: 6.998

2.  Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy.

Authors:  T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty
Journal:  Lancet       Date:  1984-03-17       Impact factor: 79.321

3.  Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis.

Authors:  O W Kamel; M van de Rijn; L M Weiss; G J Del Zoppo; P K Hench; B A Robbins; P G Montgomery; R A Warnke; R F Dorfman
Journal:  N Engl J Med       Date:  1993-05-06       Impact factor: 91.245

4.  Reversible lymphomas.

Authors:  J B Shiroky; M M Newkirk
Journal:  N Engl J Med       Date:  1993-11-25       Impact factor: 91.245

5.  Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangements.

Authors:  T Shimamoto; T Iguchi; K Ando; T Katagiri; T Tauchi; Y Ito; M Yaguchi; K Miyazawa; Y Kimura; M Masuda; H Mizoguchi; K Ohyashiki
Journal:  Br J Haematol       Date:  2001-08       Impact factor: 6.998

Review 6.  Spontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature.

Authors:  Richard D Baird; Richard Nellis van Zyl-Smit; Timothy Dilke; Sara E Scott; Saad M B Rassam
Journal:  Br J Haematol       Date:  2002-08       Impact factor: 6.998

7.  Complications of immunosuppression associated with weekly low dose methotrexate.

Authors:  J B Shiroky; A Frost; J D Skelton; D G Haegert; M M Newkirk; C Neville
Journal:  J Rheumatol       Date:  1991-08       Impact factor: 4.666

8.  Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.

Authors:  H Enright; H S Jacob; G Vercellotti; R Howe; M Belzer; W Miller
Journal:  Br J Haematol       Date:  1995-10       Impact factor: 6.998

Review 9.  Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study.

Authors:  K G Moder; A Tefferi; M D Cohen; D M Menke; H S Luthra
Journal:  Am J Med       Date:  1995-09       Impact factor: 4.965

10.  First report of a B cell lymphoproliferative disorder arising in a patient treated with immune suppressants for severe aplastic anemia.

Authors:  V Dorr; G Doolittle; J Woodroof
Journal:  Am J Hematol       Date:  1996-06       Impact factor: 10.047

View more
  4 in total

1.  Sudden appearance and spontaneous regression of diffuse large B cell lymphoma in a man with a broken arm.

Authors:  Peter A Engel; Ching Lee
Journal:  BMJ Case Rep       Date:  2009-03-05

Review 2.  Response to cyclosporine therapy in patients with myelodysplastic syndrome: a clinical study of 12 cases and literature review.

Authors:  Masao Ogata; Eiichi Ohtsuka; Tomoyuki Imamura; Junji Ikewaki; Yuko Ogata; Kazuhiro Kohno; Toshiyuki Nakayama; Keiji Ono; Yoshio Saburi; Hiroshi Kikuchi; Masaru Nasu
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

3.  Apparent spontaneous regression of malignant neoplasms after radiography: Report of four cases.

Authors:  Jun Sasaki; Hideo Kurihara; Yoshishige Nakano; Kohji Kotani; Eisuke Tame; Akira Sasaki
Journal:  Int J Surg Case Rep       Date:  2016-05-31

4.  Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy.

Authors:  Masahiro Ohara; Kokoro Ozaki; Takuya Ohkubo; Akane Yamada; Yoshiyuki Numasawa; Keisuke Tanaka; Shohei Tomii; Satoru Ishibashi; Nobuo Sanjo; Takanori Yokota
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.